HHC Ban: Youth Mental Health Concerns Trigger Government Action
Ireland Bans HHC: New Controls on Potent Cannabis-Like substance amidst Mental Health Concerns
Table of Contents
Dublin, Ireland – Ireland has officially classified Hexahydrocannabinol (HHC) as a controlled drug, a notable move aimed at curbing its widespread availability and mitigating associated public health risks, especially concerning mental health. The Department of health announced the reclassification, which places HHC under the Misuse of Drugs Acts, following its identification by the EU and the UN Commission for Narcotic Drugs as a substance posing a serious threat.
HHC: A Growing Concern in Ireland
HHC, a synthetic cannabinoid that produces effects similar to THC, the psychoactive compound in cannabis, has been increasingly prevalent in Ireland as its first detection in 2022. It has been commonly sold through various channels, including e-cigarettes or vape pens, herbal mixtures, oils, edible jellies and cakes, and tinctures.
The substance has been linked to episodes of psychosis and hospitalisation.A recent study conducted by researchers at University Hospital galway (UHG) highlighted the severity of the issue,finding HHC to be the second most common drug used by patients presenting with psychosis over a 21-month period.
This reclassification comes after the College of Psychiatrists of Ireland expressed strong criticism earlier this month, stating it was “beggars belief” that products containing HHC remained available without restrictions. The college emphasized that HHC has caused significant damage to people’s mental health.
Government Action and Public Health Priorities
Minister for Health Jennifer Carroll MacNeill stated that the marketing of HHC, particularly in attractive packaging and forms like vapes and edible jellies, is a intentional ploy to target young people.She stressed that these presentations mask the drug’s harmful effects on youth mental health and its addictive potential. “Our priority is to advance measures that enable us to protect and support the health of our population,” Minister Carroll MacNeill affirmed.
The Department of Health’s statement confirmed that HHC is now among 14 new substances, including synthetic opioids and semi-synthetic cannabinoids, classified as controlled drugs. this action is a direct response to their identification by international bodies as posing a serious risk to public health.
Expert Reactions and Future Concerns
the Chair of the Addiction Faculty at the College of psychiatrists of Ireland, Professor Bobby Smyth, expressed frustration over the delay in banning HHC in Ireland, noting that many European countries had implemented similar bans months prior.Professor smyth, also a Clinical Professor of Public Health and Primary Care at Trinity college Dublin, voiced concerns about what might happen next.
“How quickly can vape shops take HHC off the shelves and replace it with something similar but different?” he questioned. he highlighted the worry that some users, having become accustomed to HHC over its years of availability in Ireland, might seek similar alternatives, thus perpetuating demand.
The addition of HHC to the schedules of the Misuse of Drugs Acts will grant An Garda Síochána (Irish police) enhanced powers to combat the illicit trade of the substance.
Professor Smyth also raised questions about why HHC was not initially covered under the psychoactive Substances Act 2010. This act was instrumental in dismantling the “headshop” problem in Ireland, where businesses could circumvent drug laws by quickly altering their product formulations when specific substances were made illegal. He recalled that the ban on headshops led to a noticeable decrease in psychotic patients, a trend he hopes to see replicated with the HHC ban.The College of Psychiatrists of Ireland reiterated its earlier stance, emphasizing the critical need for restrictions on such man-made drugs that mimic cannabis effects and have demonstrably harmed mental well-being.